Lv2
175 积分 2021-07-14 加入
Comparison of subcutaneous injection versus intravenous infusion of cytarabine for induction therapy in adult acute myeloid leukemia
18天前
已关闭
Benefit with glofitamab plus chemotherapy in transplant-ineligible R/R DLBCL
27天前
已完结
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
28天前
已完结
Efficacy of carfilzomib-based regimens as induction/consolidation therapy in newly diagnosed multiple myeloma: A meta-analysis
1个月前
已关闭
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
1个月前
已完结
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
1个月前
已关闭
High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy
2个月前
已完结
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
4个月前
已完结
Strategies following failure of CAR-T-cell therapy in non-Hodgkin lymphoma
4个月前
已完结
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
